T1	PROC 104 118	diagnosticados
#1	AnnotatorNotes T1	C0011900; Diagnosis; Diagnostic Procedure
T2	DISO 123 151	Linfoma no Hodgkin indolente
#2	AnnotatorNotes T2	C1334170; Indolent Non-Hodgkin Lymphoma; Neoplastic Process
T3	PROC 175 192	Estudio de Fase 2
T4	DISO 219 247	Linfoma no Hodgkin indolente
#3	AnnotatorNotes T4	C1334170; Indolent Non-Hodgkin Lymphoma; Neoplastic Process
T5	DISO 284 312	Linfoma no Hodgkin indolente
#4	AnnotatorNotes T5	C1334170; Indolent Non-Hodgkin Lymphoma; Neoplastic Process
T6	DISO 347 375	Linfoma no Hodgkin indolente
#5	AnnotatorNotes T6	C1334170; Indolent Non-Hodgkin Lymphoma; Neoplastic Process
T7	PROC 428 439	diagnóstico
#6	AnnotatorNotes T7	C0011900; Diagnosis; Diagnostic Procedure
T8	DISO 443 456	LNH indolente
#7	AnnotatorNotes T8	C1334170; Indolent Non-Hodgkin Lymphoma; Neoplastic Process
T10	DISO 663 685	enfermedad refractaria
#9	AnnotatorNotes T10	C1514815; Refractory Disease; Finding
T11	CHEM 688 697	rituximab
#10	AnnotatorNotes T11	C0393022; rituximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T12	DISO 701 722	Enfermedad mensurable
T13	ANAT 730 747	ganglio linfático
#11	AnnotatorNotes T13	C0024204; lymph nodes; Body Part, Organ, or Organ Component | C1269047; Entire lymph node; Body Part, Organ, or Organ Component
T14	DISO 750 762	masa tumoral
#12	AnnotatorNotes T14	C3273930; Tumor Mass; Finding
T15	DISO 1437 1492	Infecciones bacterianas, micóticas o víricas sistémicas
#13	AnnotatorNotes T15	C4285789; Systemic viral infection; Disease or Syndrome + C0553576; Systemic mycosis; Disease or Syndrome + C4285778; Systemic bacterial infection; Disease or Syndrome
T16	ANAT 831 839	hepática
#14	AnnotatorNotes T16	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T17	PROC 896 908	tratamientos
#15	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	PROC 966 977	Tratamiento
#16	AnnotatorNotes T18	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T19	CHEM 989 1008	inhibidores de PI3K
#17	AnnotatorNotes T19	C1519050; Phosphatidylinositide 3-Kinase Inhibitor; Organic Chemical · Pharmacologic Substance
T20	CHEM 1011 1032	inhibidores de la BTK
#18	AnnotatorNotes T20	C4086017; BTK Inhibitor; Pharmacologic Substance
T21	PROC 1051 1097	alotrasplante de células madre hematopoyéticas
#19	AnnotatorNotes T21	C1705576; Allogeneic Hematopoietic Stem Cell Transplantation; Therapeutic or Preventive Procedure
T22	ANAT 1068 1097	células madre hematopoyéticas
#20	AnnotatorNotes T22	C0018956; Hematopoietic stem cells; Cell
T23	PROC 1108 1119	Tratamiento
#21	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	PROC 1131 1144	quimioterapia
#22	AnnotatorNotes T24	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T25	PROC 1146 1164	terapia oncológica
T26	CHEM 1169 1185	inmunodepresores
#23	AnnotatorNotes T26	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T27	CHEM 1194 1219	fármacos en investigación
#24	AnnotatorNotes T27	C0013230; Investigational New Drugs; Pharmacologic Substance
T28	CHEM 1268 1275	fármaco
#25	AnnotatorNotes T28	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T29	DISO 1291 1293	LF
#26	AnnotatorNotes T29	C0024301; Lymphoma, Follicular; Neoplastic Process
T30	DISO 1360 1367	linfoma
#27	AnnotatorNotes T30	C0024299; Lymphoma; Neoplastic Process
T31	DISO 1384 1434	LNH del sistema nervioso central (SNC) sintomático
T32	ANAT 1392 1416	sistema nervioso central
#28	AnnotatorNotes T32	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T33	ANAT 1418 1421	SNC
#29	AnnotatorNotes T33	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T34	PROC 1530 1541	tratamiento
#30	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	PROC 600 637	régimen de inducción de quimioterapia
#32	AnnotatorNotes T36	C0857127; Induction procedure; Therapeutic or Preventive Procedure + C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T37	PROC 809 811	TC
#33	AnnotatorNotes T37	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T38	ANAT 823 828	renal
#34	AnnotatorNotes T38	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T39	PROC 1099 1103	TCPH
T40	CHEM 85 92	IPI-145
#35	AnnotatorNotes T40	C3274621; IPI-145; Organic Chemical · Pharmacologic Substance
T41	CHEM 196 203	IPI-145
#36	AnnotatorNotes T41	C3274621; IPI-145; Organic Chemical · Pharmacologic Substance
T42	PROC 640 643	RIT
#37	AnnotatorNotes T42	C0857127; Induction procedure; Therapeutic or Preventive Procedure + C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T43	Date 13 17	2013
T44	LIVB 96 103	sujetos
#38	AnnotatorNotes T44	C0681850; Study Subject; Group
T46	LIVB 207 214	sujetos
#39	AnnotatorNotes T46	C0681850; Study Subject; Group
T50	LIVB 416 423	Sujetos
#40	AnnotatorNotes T50	C0681850; Study Subject; Group
T51	LIVB 480 487	sujetos
#41	AnnotatorNotes T51	C0681850; Study Subject; Group
T54	Duration 555 566	los 6 meses
T55	CONC 581 593	última dosis
T56	LIVB 651 658	sujetos
#42	AnnotatorNotes T56	C0681850; Study Subject; Group
T58	LIVB 949 961	investigador
#43	AnnotatorNotes T58	C0035173; Research Personnel; Professional or Occupational Group
T59	Duration 1223 1236	las 4 semanas
T60	CONC 1250 1263	primera dosis
T61	LIVB 1462 1471	micóticas
#44	AnnotatorNotes T61	C0016832; Fungi; Fungus
T62	LIVB 1474 1481	víricas
#45	AnnotatorNotes T62	C0042776; Virus; Virus
T65	PHYS 1082 1097	hematopoyéticas
#46	AnnotatorNotes T65	C0018951; Hematopoiesis; Organ or Tissue Function
T66	LIVB 1449 1460	bacterianas
#47	AnnotatorNotes T66	C0004611; Bacteria; Bacterium
T45	PHYS 815 839	Función renal y hepática
#48	AnnotatorNotes T45	C0232804; Renal function; Organ or Tissue Function + C0232741; Liver function; Organ or Tissue Function
T47	Date 1493 1501	en curso
A2	Status T36 History_of
A4	Status T42 History_of
A5	Status T18 History_of
A6	Status T19 History_of
A7	Status T20 History_of
A8	Status T21 History_of
A9	Status T39 History_of
A10	Status T23 History_of
A11	Status T24 History_of
A12	Status T25 History_of
A13	Status T26 History_of
A14	Status T27 History_of
T48	Neg_cue 514 521	ninguna
T49	Observation 522 531	respuesta
A15	Assertion T49 Negated
#49	AnnotatorNotes T49	C4055223; Clinical Response; Finding (?)
T52	Observation 534 544	progresión
A16	Assertion T52 Negated
#50	AnnotatorNotes T52	C1457868; Worse; Finding
T53	Spec_cue 909 923	potencialmente
T57	Quantifier_or_Qualifier 924 933	curativos
A17	Assertion T57 Speculated
R1	Experiences Arg1:T44 Arg2:T40	
R2	Experiences Arg1:T44 Arg2:T2	
R3	Experiences Arg1:T46 Arg2:T41	
R4	Experiences Arg1:T46 Arg2:T4	
T63	Quantifier_or_Qualifier 248 259	refractario
#51	AnnotatorNotes T63	C0205269; Unresponsive to Treatment; Functional Concept
R5	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T63	
T64	Quantifier_or_Qualifier 376 387	refractario
#52	AnnotatorNotes T64	C0205269; Unresponsive to Treatment; Functional Concept
R6	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T64	
R7	Experiences Arg1:T50 Arg2:T8	
T67	Observation 461 471	progresión
#53	AnnotatorNotes T67	C1457868; Worse; Finding
R8	Before Arg1:T8 Arg2:T67	
R9	Experiences Arg1:T50 Arg2:T67	
R10	Negation Arg1:T48 Arg2:T49	
R11	Negation Arg1:T48 Arg2:T52	
R12	Experiences Arg1:T51 Arg2:T49	
R13	Experiences Arg1:T51 Arg2:T52	
R14	Overlap Arg1:T49 Arg2:T54	
R15	Overlap Arg1:T52 Arg2:T54	
R16	After Arg1:T52 Arg2:T55	
R17	After Arg1:T49 Arg2:T55	
R20	Has_Dose_or_Strength Arg1:T42 Arg2:T55	
R24	Experiences Arg1:T51 Arg2:T36	
R25	Experiences Arg1:T51 Arg2:T42	
R26	Experiences Arg1:T56 Arg2:T10	
R27	Experiences Arg1:T56 Arg2:T11	
R29	Location_of Arg1:T13 Arg2:T12	
#54	AnnotatorNotes T12	C1513041; Measurable Disease; Disease or Syndrome
T68	Result_or_Value 763 773	>o= 1,5 cm
R30	Has_Result_or_Value Arg1:T14 Arg2:T68	
R33	Location_of Arg1:T38 Arg2:T45	
R34	Location_of Arg1:T16 Arg2:T45	
T69	Quantifier_or_Qualifier 840 848	adecuada
#55	AnnotatorNotes T69	C0205411; Adequate; Qualitative Concept
R35	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T69	
R36	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T57	
R37	Speculation Arg1:T53 Arg2:T57	
R38	Used_for Arg1:T19 Arg2:T18	
R39	Used_for Arg1:T20 Arg2:T18	
R44	Used_for Arg1:T26 Arg2:T25	
R45	Used_for Arg1:T27 Arg2:T25	
R46	Overlap Arg1:T27 Arg2:T59	
R47	Overlap Arg1:T26 Arg2:T59	
R48	Has_Dose_or_Strength Arg1:T28 Arg2:T60	
R49	Before Arg1:T25 Arg2:T60	
R50	Before Arg1:T24 Arg2:T60	
R51	Before Arg1:T23 Arg2:T60	
T70	Quantifier_or_Qualifier 1297 1305	grado 3B
R52	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T70	
T71	Observation 1308 1343	evidencia clínica de transformación
R53	Overlap Arg1:T29 Arg2:T71	
T72	Quantifier_or_Qualifier 1368 1380	más agresivo
R54	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T72	
R55	Before Arg1:T71 Arg2:T30	
R56	Location_of Arg1:T32 Arg2:T31	
R57	Location_of Arg1:T33 Arg2:T31	
R58	Causes Arg1:T66 Arg2:T15	
R59	Causes Arg1:T61 Arg2:T15	
R60	Causes Arg1:T62 Arg2:T15	
R61	Overlap Arg1:T15 Arg2:T47	
T73	CONC 1519 1541	iniciar el tratamiento
R62	Overlap Arg1:T15 Arg2:T73	
R18	Has_Dose_or_Strength Arg1:T36 Arg2:T55	
#8	AnnotatorNotes R20	(?)
#31	AnnotatorNotes R18	(?)
#56	AnnotatorNotes T55	C1762893; Date last dose; Temporal Concept
#57	AnnotatorNotes R48	(?)
#58	AnnotatorNotes T60	C5236155; Date of First Dose; Temporal Concept
#59	AnnotatorNotes T47	C0521116; Current (present time); Temporal Concept
#60	AnnotatorNotes T3	C0282460; Phase 2 Clinical Trials; Research Activity
#61	AnnotatorNotes T57	C1880198; Cure (remedy); Conceptual Entity
#62	AnnotatorNotes T39	C0472699; Hemopoietic stem cell transplant; Therapeutic or Preventive Procedure
#63	AnnotatorNotes T25	C0920425; cancer treatment; Therapeutic or Preventive Procedure
A1	Experiencer T46 Patient
A3	Experiencer T44 Patient
A18	Experiencer T50 Patient
A19	Experiencer T51 Patient
A20	Experiencer T56 Patient
A21	Experiencer T58 Other
A22	Status T17 Future
